Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/19/1998WO1998051799A1 Novel differentiation inhibitor
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051797A1 Human vesicle binding protein
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051795A1 Double-stranded rna-binding protein
11/19/1998WO1998051793A1 Apo-2 RECEPTOR
11/19/1998WO1998051792A1 Fac molecules and uses thereof
11/19/1998WO1998051788A2 Method and construct for inhibition of cell migration
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051784A1 Modiified arginine deiminase
11/19/1998WO1998051782A2 Human 3-hydroxyisobutyryl-coenzyme a hydrolase
11/19/1998WO1998051708A1 A method for the improvement of neuronal regeneration
11/19/1998WO1998051707A1 Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051705A1 Peptides with antiviral activity
11/19/1998WO1998051704A1 PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS
11/19/1998WO1998051703A1 20(s) camptothecin glycoconjugates
11/19/1998WO1998051684A1 Antithrombotic compound
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051660A1 Methods and compositions for the selective modification of nucleic acids
11/19/1998WO1998051354A2 Compositions for morphogen-induced osteogenesis
11/19/1998WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998WO1998051348A2 Sustained-release delayed gels
11/19/1998WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998WO1998051345A2 Method for dislodging infiltrated leukocytes from a tissue
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051343A1 Use of an anti-lfa1 monoclonal antibody in kidney transplantation
11/19/1998WO1998051340A1 Fas ligand expressing antigen presenting cells for tolerance induction
11/19/1998WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/19/1998WO1998051336A1 Targeted delivery to t lymphocytes
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051334A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998WO1998051333A1 Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage
11/19/1998WO1998051332A1 Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
11/19/1998WO1998051331A1 Somatostatin and somatostatin agonists for decreasing body weight
11/19/1998WO1998051330A1 Method and compositions for treating hyperlipidemia and other conditions
11/19/1998WO1998051329A1 Cachexia remedy
11/19/1998WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
11/19/1998WO1998051327A1 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
11/19/1998WO1998051326A1 Inhibition of angiogenesis by verotoxins
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998WO1998051323A1 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
11/19/1998WO1998051322A1 CONOPEPTIDES AuIA, AuIB AND AuIC
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051317A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells
11/19/1998WO1998051296A1 Method of reducing immunological tolerance to malignancy
11/19/1998WO1998051295A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
11/19/1998WO1998051260A2 Use of d-arginine and/or l-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
11/19/1998WO1998040483A3 28 human secreted proteins
11/19/1998WO1998037180A3 Hcv fusion protease and polynucleotide encoding same
11/19/1998WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
11/19/1998WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease
11/19/1998WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998WO1998033929A3 Use of a polypeptide as cell receptor for adenoviruses
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998WO1998026051A3 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation
11/19/1998DE3845000C2 Compsn. contg. somatostatin analogues for treating breast cancer
11/19/1998DE19801037A1 New camptothecin glyco-conjugate compounds
11/19/1998DE19720011A1 New modified aminoacid derivatives
11/19/1998CA2291436A1 20(s) camptothecin glycoconjugates
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290592A1 Somatostatin and somatostatin agonists for decreasing body weight
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998CA2289960A1 Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein
11/19/1998CA2289910A1 Therapeutic agent for cachexia
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2289625A1 Antithrombotic compound
11/19/1998CA2289619A1 Methods and compositions for the selective modification of nucleic acids
11/19/1998CA2289550A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998CA2289490A1 Method and compositions for treating hyperlipidemia and other conditions
11/19/1998CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998CA2289117A1 Method and construct for inhibition of cell migration
11/19/1998CA2288902A1 Compositions for morphogen-induced osteogenesis
11/19/1998CA2288690A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2288218A1 Novel differentiation-inhibitor
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2287911A1 Apo-2 receptor
11/19/1998CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998CA2286875A1 Chemical compounds
11/19/1998CA2259956A1 Peptides promoting the activation of latent tgf-.beta. and method for screening tgf-.beta. activity regulators
11/19/1998CA2259425A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
11/18/1998EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines
11/18/1998EP0878544A1 Epididymis specific DNA sequences and their use
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878480A1 A method for the improvement of neuronal regeneration
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0878201A1 Preventives and remedies for thrombocytopenia
11/18/1998EP0878200A1 Therapeutic agent for ophthalmic diseases
1 ... 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 ... 3163